PF-06688992 is an antibody-drug conjugate (ADC) that targets the GD3 antigen, consisting of a humanized anti-GD3 monoclonal antibody (huR24) linked to a chemotherapeutic agent. It can induce apoptosis in tumor cells and holds potential for research in tumors with overexpression of GD3, such as melanoma.